MYRIAD GENETICS INC — Director's Dealing 2021

Aug 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2021-08-23

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-23	Common Stock	M	10000	$27.07	Acquired	242550	Direct
2021-08-23	Common Stock	S	10000	$35.57	Disposed	232550	Direct
2021-08-23	Common Stock	M	40000	$27.07	Acquired	272550	Direct
2021-08-23	Common Stock	S	40000	$35.07	Disposed	232550	Direct
2021-08-24	Common Stock	M	30000	$27.07	Acquired	262550	Direct
2021-08-24	Common Stock	S	30000	$35.57	Disposed	232550	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-23	Non-Qualified Stock Option (right to buy)	$27.07	M	10000	Disposed	2022-09-12	Common Stock (10000)	Direct
2021-08-23	Non-Qualified Stock Option (right to buy)	$27.07	M	40000	Disposed	2022-09-12	Common Stock (40000)	Direct
2021-08-24	Non-Qualified Stock Option (right to buy)	$27.07	M	30000	Disposed	2022-09-12	Common Stock (30000)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The shares subject to this option are fully vested and exercisable.